These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2153577)

  • 1. Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase.
    Aakerlund L; Gether U; Fuhlendorff J; Schwartz TW; Thastrup O
    FEBS Lett; 1990 Jan; 260(1):73-8. PubMed ID: 2153577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist.
    Fuhlendorff J; Gether U; Aakerlund L; Langeland-Johansen N; Thøgersen H; Melberg SG; Olsen UB; Thastrup O; Schwartz TW
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):182-6. PubMed ID: 2153286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of functional neuropeptide Y receptors in a human neuroblastoma cell line.
    Gordon EA; Kohout TA; Fishman PH
    J Neurochem; 1990 Aug; 55(2):506-13. PubMed ID: 2164571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NPY upregulates genes containing cyclic AMP response element in human neuroblastoma cell lines bearing Y1 and Y2 receptors: involvement of CREB.
    Sheriff S; Dayal R; Kasckow J; Regmi A; Chance W; Fischer J; Balasubramaniam A
    Regul Pept; 1998 Sep; 75-76():309-18. PubMed ID: 9802424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells.
    Morgan DG; Kulkarni RN; Hurley JD; Wang ZL; Wang RM; Ghatei MA; Karlsen AE; Bloom SR; Smith DM
    Diabetologia; 1998 Dec; 41(12):1482-91. PubMed ID: 9867216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
    Connor M; Yeo A; Henderson G
    Br J Pharmacol; 1997 Feb; 120(3):455-63. PubMed ID: 9031749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY.
    Wahlestedt C; Regunathan S; Reis DJ
    Life Sci; 1992; 50(4):PL7-12. PubMed ID: 1310131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y binding and inhibition of cAMP accumulation in human neuroepithelioma cells.
    Lobaugh LA; Blackshear PJ
    Am J Physiol; 1990 May; 258(5 Pt 1):C913-22. PubMed ID: 2159234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type.
    Larhammar D; Blomqvist AG; Yee F; Jazin E; Yoo H; Wahlested C
    J Biol Chem; 1992 Jun; 267(16):10935-8. PubMed ID: 1317848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass.
    Kirby DA; Koerber SC; May JM; Hagaman C; Cullen MJ; Pelleymounter MA; Rivier JE
    J Med Chem; 1995 Oct; 38(22):4579-86. PubMed ID: 7473586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor.
    Krause J; Eva C; Seeburg PH; Sprengel R
    Mol Pharmacol; 1992 May; 41(5):817-21. PubMed ID: 1316999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for two neuropeptide Y receptors mediating vasoconstriction.
    Modin A; Pernow J; Lundberg JM
    Eur J Pharmacol; 1991 Oct; 203(2):165-71. PubMed ID: 1666044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific 125I neuropeptide Y binding to intact cultured bovine adrenal medulla capillary endothelial cells.
    Sanabria P; Silva WI
    Microcirculation; 1994 Dec; 1(4):267-73. PubMed ID: 8790595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pertussis toxin-insensitive calcium influx mediated by neuropeptide Y2 receptors in a human neuroblastoma cell line.
    Lynch JW; Lemos VS; Bucher B; Stoclet JC; Takeda K
    J Biol Chem; 1994 Mar; 269(11):8226-33. PubMed ID: 8132547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
    Gibbs JL; Diogenes A; Hargreaves KM
    Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-protein coupling and signalling of Y1-like neuropeptide Y receptors in SK-N-MC cells.
    Feth F; Rascher W; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):1-7. PubMed ID: 1663584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways.
    Misra S; Murthy KS; Zhou H; Grider JR
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1154-62. PubMed ID: 15308651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
    Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B
    Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a Y1-preferring NPY/PYY receptor in HT-29 cells.
    Mannon PJ; Mervin SJ; Sheriff-Carter KD
    Am J Physiol; 1994 Nov; 267(5 Pt 1):G901-7. PubMed ID: 7977753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.